Type
. [Chloramphenicol in the treatment of the leprous reaction]. Acta leprologica. 1979;(76-77):325-9.
Type
. [Reverse reaction during BCG therapy followed by antibiochemotherapy]. Acta leprologica. 1979;(76-77):319-20.
Type
. [Inflammatory tuberculoid leprosy and borderline leprosy treated with long-acting sulfamides (fanasil). Clinical, bacteriologic and immunologic changes in vivo and in vitro followed for 18 to 36 months]. Acta leprologica. 1979;(76-77):315-7.
Type
. [In vitro immunologic changes in 6 lepromatous leprosy or borderline leprosy patients treated with BCG alone or BCG and lepromin for 12 to 20 months, followed by BCG and antibiochemotherapy for 1 to 2 years]. Acta leprologica. 1979;(76-77):311-4.
Type
. [Tuberculoid leprosy and inflammatory borderline leprosy managed by desensitisation to lepromin. Preliminary results]. Acta leprologica. 1979;(76-77):303-9.
Type
. [In vitro immunologic changes in 4 patients with lepromatous leprosy treated for 1 year with rifampicin and sulfones and left untreated the following year]. Acta leprologica. 1979;(76-77):301-2.
Type
. [In vitro immunologic changes in 7 patients with lepromatous leprosy and borderline leprosy treated with levamisole]. Acta leprologica. 1979;(76-77):295-300.
Type
. [In vitro immunologic changes in 4 patients with lepromatous leprosy and 4 patients with borderline leprosy treated with Neisseria perflava for 17 to 25 months]. Acta leprologica. 1979;(76-77):291-3.
Type
. [Program for the control of leprosy in the Dominican Republic]. Acta leprologica. 1979;(76-77):29-40.
Type
. [Plasma exchange in the treatment of lepromatous leprosy]. Acta leprologica. 1979;(76-77):285-90.